Editors' note: Depressed TSH level as a predictor of poststroke fatigue in patients with acute ischemic stroke
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In the article “Depressed TSH level as a predictor of poststroke fatigue in patients with acute ischemic stroke”, Wang et al. found that serum levels of thyroid stimulating hormone were inversely associated with risk and severity of poststroke fatigue (PSF) in 704 consecutive patients with ischemic stroke, suggesting that neuroendocrine responses could have a role in PSF. In response, Dr. Bunevicius notes that thyroid hormone concentrations fluctuate in the acute phase of stroke, making it difficult to estimate whether single-point thyroid-related measurements reflect prior or new hormonal balance or an acute response, and provides examples of medications and interventions that may interfere with thyroid gland functioning in the acute stroke setting. Dr. Bunevicius also suggests examining the relationship of the triiodothyronine to thyroxin ratio and PFS severity. The authors did not respond to these comments.
In the article “Depressed TSH level as a predictor of poststroke fatigue in patients with acute ischemic stroke”, Wang et al. found that serum levels of thyroid stimulating hormone were inversely associated with risk and severity of poststroke fatigue (PSF) in 704 consecutive patients with ischemic stroke, suggesting that neuroendocrine responses could have a role in PSF.
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- © 2019 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
Dr. Robert Pitceathly and Dr. William Macken
► Watch
Related Articles
Alert Me
Recommended articles
-
Article
Depressed TSH level as a predictor of poststroke fatigue in patients with acute ischemic strokeJinjing Wang, Fengli Li, Lulu Xiao et al.Neurology, October 26, 2018 -
Articles
Favorable functional outcomes in acute ischemic stroke patients with subclinical hypothyroidismFahimeh H. Akhoundi, Askar Ghorbani, Akbar Soltani et al.Neurology, June 29, 2011 -
Disputes & Debates: Editors' Choice
Reader response: Depressed TSH level as a predictor of poststroke fatigue in patients with acute ischemic strokeAdomas Bunevicius et al.Neurology, September 16, 2019 -
In Focus
Spotlight on the November 20 issueRobert A. Gross et al.Neurology, November 19, 2018